Roham Zamanian
NIH Rank #4061
- R01 Award PI
Researcher identity and coverage
- Current affiliation
- Not verified in ScienceDex.NIH award organizations may differ from a researcher's employer.
- NIH RePORTER identity
- Profile ID 9886498Search this ID in NIH RePORTER
- ScienceDex PI coverage
- FY2024 through FY2025Career claims are limited to the years shown.Metrics use this researcher's latest loaded PI award year; ScienceDex is current through FY2026.
FY2025 award categories
- Internal Medicine
NIH Funding · FY2025
Linked Award Amount
$2.7M
Full award amounts, FY2025
Award Records
2
Records listing this PI
Award-Linked Rank
#4,061
By linked amount among FY2025 PIs
Earliest Year Loaded
2024
ScienceDex PI coverage
Award-linked funding history
Linked NIH award amounts and rank by fiscal year.
FY2025 award records by amount
NIH award records listing Roham Zamanian as a PI. Multi-PI records show the full award amount for context.
- 1UG3HL180990-01UG31/2 A Phase 2 Study of Elafin (Tiprelestat) for the Treatment of Pulmonary Arterial Hypertension (PAH)$2Maward amount
- 5R01HL159886-05R01Case-Control Study of Methamphetamine in Pulmonary Arterial Hypertension$714Kaward amount
Award organizations
Organizations that administered FY2025 awards listing Roham Zamanian as a PI.
Coverage and award-record milestones
Computed from the fiscal years currently available in ScienceDex.
- 2024ScienceDex Coverage BeginsEarliest loaded PI award records: FY2024
- 2024$500K Cumulative Linked Award Amount
- 2024R01 Award Record
- 2025$1M Cumulative Linked Award Amount
- 2025$2M Cumulative Linked Award Amount
- 2025Reached Top 50% by Award-Linked RankRanked #4061
- 2025Reached Top 25% by Award-Linked RankRanked #4061
- 2025Multiple Award OrganizationsAwards administered by 2 organizations
Shared-award investigators
Other investigators listed on at least one of the same NIH award records as Roham Zamanian.